Kyverna Therapeutics Inc.

KYTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.50

+$0.38 (+5.34%)

Sep 22, 2026, 1:01 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023
Cash & Equivalents	31.81M	32.19M	124.09M	34.16M	53.44M	56.87M	96.62M	104.66M	131.62M	224.29M	34.65M	22.97M	224.29M
Short-Term Investments	167.62M	204.25M	155.16M	136.97M	158.24M	185.78M	189.36M	216.92M	214.62M	145.51M	22.9M	54.31M	145.51M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	4M	5.57M	5.45M	5.91M	4.6M	4.2M	5.26M	2.44M	1.79M	1.74M	3.92M	2.01M	1.74M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	7.12M	5.28M	3.7M	3.79M	2.65M	5M	4.62M	3.79M	2.59M	5.69M	3.12M	2.14M	n/a
Total Current Assets	206.54M	241.73M	282.95M	174.93M	214.33M	247.65M	290.6M	325.37M	348.82M	375.49M	60.66M	79.41M	375.49M
Property-Plant & Equipment	9.29M	9.73M	5.42M	6.32M	7.58M	8.8M	10.66M	11.38M	12.51M	12.75M	10.61M	11.07M	12.75M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13.28M	15.3M	10.87M	12.23M	12.18M	13M	15.92M	13.82M	14.29M	14.5M	14.53M	13.08M	14.5M
Total Assets	219.82M	257.02M	293.83M	187.16M	226.51M	260.66M	304.65M	339.2M	363.12M	389.98M	75.2M	92.49M	389.98M
Account Payables	2.93M	11.6M	5.31M	3.02M	9.92M	8.47M	4.62M	9.93M	4.86M	7.45M	4.36M	3.02M	7.45M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.53M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	21.28M	3.11M	9.99M	6.96M	4.97M	3.08M	4.88M	4.44M	2.72M	1.36M	9.77M	2.95M	n/a
Total Current Liabilities	22.8M	29.67M	36.49M	33.87M	39.79M	33.29M	33.76M	30.99M	23.48M	21.87M	19.86M	16.87M	21.87M
Long-Term Debt	6.59M	24.81M	24.74M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	24.88M	n/a	n/a	n/a	n/a	n/a	n/a	296K	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	31.47M	31.77M	25.06M	1.34M	2.34M	3.35M	4.3M	5.5M	6.13M	7.13M	6.16M	6.84M	7.13M
Total Liabilities	54.27M	61.44M	61.55M	35.21M	42.13M	36.65M	38.06M	36.49M	29.61M	28.99M	26.02M	23.72M	28.99M
Total Debt	8.12M	33.76M	29.03M	5.02M	5.92M	6.94M	8.24M	9.14M	10M	10.85M	9.08M	9.64M	10.85M
Book Value	165.55M	195.58M	232.28M	151.95M	184.38M	224.01M	266.59M	302.71M	333.51M	360.99M	49.18M	68.77M	360.99M
Book Value Per Share	2.72	3.24	4.93	3.50	4.27	5.18	6.17	7.01	7.73	15.20	1.14	1.59	8.37
Common Stock	1K	1K	1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-502.87M	-464.56M	-424.83M	-387.02M	-350.24M	-308.16M	-263.52M	-226.03M	-191.54M	-162.74M	-136.04M	-115.38M	-162.74M
Comprehensive Income	-142K	-96K	97K	29K	-20K	-1K	105K	153K	-37K	-1K	4K	5K	-1K
Shareholders Equity	165.55M	195.58M	232.28M	151.95M	184.38M	224.01M	266.59M	302.71M	333.51M	360.99M	49.18M	68.77M	360.99M
Total Investments	167.62M	204.25M	155.16M	136.97M	158.24M	185.78M	189.36M	216.92M	214.62M	145.51M	22.9M	54.31M	145.51M